Oral lichen planus: clinical and histopathological considerations  by Sousa, Fernando Augusto Cervantes Garcia de & Rosa, Luiz Eduardo Blumer
284
Brazilian Journal of otorhinolaryngology 74 (2) March/april 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Oral lichen planus: clinical 
and histopathological 
considerations
   Summary
Fernando Augusto Cervantes Garcia de Sousa1, 
Luiz Eduardo Blumer Rosa2
 1 Master in Oral Biopathology, FOSJC/UNESP. Dental Surgeon.
 2 Adjunct Professor of Oral Pathology, FOSJC/UNESP, Dental Surgeon.
Address for correspondence: Fernando Augusto Cervantes Garcia de Sousa - Rua Irma Maria Demétria Kfruri 196 Jardim Esplanada II 
São Jose dos Campos SP 12242-500.
CAPES.
Paper submitted to the ABORL-CCF SGP (Management Publications System) on July 27th, 2006 and accepted for publication on September 30th, 2006. cod. 3302.
Oral lichen planus is one of the most common 
dermatological diseases presenting in the oral cavity; the 
prevalence in the general population is 1% to 2%. Although 
relatively frequent, oral lichen planus is the target of 
much controversy, especially in relation to its potential for 
malignancy. Aim: This study aimed to make clinical and 
histopathological considerations regarding oral lichen planus 
to increase the level of knowledge about this condition among 
health professionals, underlining the importance of long-term 
follow-up of these patients. Conclusion: The possibility of 
this lesion to turn malignant justifies the importance of long 
term follow up for patients with such disease. 
Keywords: diagnosis, literature review, lichen planus, mouth 
mucosa.
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INTRODUCTION
Lichen planus is a chronic inflammatory disease that 
affects the skin and mucosa. It is one of the most common 
dermatological conditions involving the oral cavity; its 
prevalence is 1% to 2% in the general population. There 
is a strong preference for the female sex1 
Sousa & Rosa2 (2005) surveyed 79 oral lichen planus 
cases diagnosed between 1974 and 2003, and found that 
women are nearly four times more affected by this con-
dition than men, and that white individuals are five and a 
half times more likely to develop this disease compared 
to other races.
These features, however, are among the few points 
of agreement about oral lichen planus; most of the remai-
ning aspects are controversial, especially it’s potential for 
malignant transformation. The aim of this paper, therefore, 
is to describe oral lichen planus clinically and histopatho-
logically, and to help disseminate this information among 
health professionals; the importance of long-term follow-
up of these patients is underlined.
ETIOPATHOGENESIS
Although oral lichen planus was initially described 
in 1869, little is known about mechanisms by which the 
disease develops.
Sugerman et al.3 (2002) believe that specific and 
non-specific mechanisms may be involved in the etiopa-
thogenesis of this condition. Specific mechanisms include 
antigen presentation by basement layer keratinocytes and 
cytotoxic T lymphocyte-caused death of antigen-specific 
keratinocytes, while non-specific mechanisms included 
mast cell degranulation and matrix metalloproteinase 
activation. These combined mechanisms appear to cause 
T lymphocytes accumulation in the lamina propria under-
lying the epithelium, as well as rupture of the basement 
membrane, intraepithelial T lymphocytes migration and 
keratinocyte apoptosis, all of which are characteristic 
of oral lichen planus. Furthermore, according to these 
authors, the chronic nature of this disease may be partly 
explained by deficient immunosuppression, mediated by 
the transforming growth factor-beta 1.
The factors that set this process in motion, however, 
have not been fully clarified. Still, stress, food such as to-
matoes, citric fruit and seasoned dishes, dental procedures, 
systemic disease, alcohol abuse, and tobacco use in all 
its forms, have been associated with disease exacerbation 
periods.4 Recently, systemic diseases, especially those re-
sulting from hepatitis C virus infection, have come under 
the spotlight.
Lodi et al.5 (2004) used the enzyme-linked immu-
nosorbent assay (ELISA) test to investigate the presence of 
antibodies against the hepatitis C virus in 581 patients, 303 
of which with a clinical and histopathological diagnosis 
of oral lichen planus, and 278 with no evidence of this 
disease (control group). Of 303 patients diagnosed with 
oral lichen planus, 58 (19.1%) were positive for the hepa-
titis C virus, compared to only nine (3.2%) in the control 
group. Furthermore, the authors reviewed the results of 24 
similar studies done between 1994 and 2003, and found a 
statistically significant difference in the proportion of serum 
positive individuals for the hepatitis C virus among patients 
with oral lichen planus compared to controls.
The relation between oral lichen planus and the 
hepatitis C virus is not consistent; the prevalence of this 
virus in such patients varies widely from 0% to over 60%, 
depending on the country in which these studies were 
conducted. It is thought that such differences are mainly 
due to geographic discrepancies in the prevalence of this 
virus within the general population.6 
Henderson et al.7 (2001) have questioned this 
hypothesis. The author assessed the oral health and 
the availability of dental treatment for hepatitis C virus 
infected-patients in the United Kingdom, and found cli-
nical evidence of lichen planus in 20% of these patients. 
This was a much higher percentage than that found in 
the general population, in which the prevalence was not 
more than 1%. This finding came to the author’s attention, 
as the prevalence of the hepatitis C virus is low; the lite-
rature shows that there is a directly proportional relation 
between the prevalence of the hepatitis C virus and oral 
lichen planus.
Cunha et al.8 (2005) noted similar findings in a stu-
dy of 134 serum positive patients for the hepatitis C virus 
in Brazil. Although the prevalence of this virus is high in 
this country, the percentage of patients with lichen planus 
was 1.5%; there was, therefore, no statistically significant 
difference compared to the control group, in which 1.1% 
of patients presented signs of the disease.
A direct association between lichen planus and the 
hepatitis C virus cannot always be demonstrated. Mico-
Llorens et al.9 (2004), for instance, found no changes in 
the oral mucosa of 100 patients infected with the hepatitis 
B or C or both viruses that participated in a study done 
by the Digestive System Pathology Unit of the “Príncipes 
de España de Bellvitge” Hospital in September and Oc-
tober 2000.
Romero et al.10 (2002), however, have underlined 
the need to investigate the presence of hepatitis C virus 
antibodies in all patients with oral lichen planus. These 
authors believe that the existence of clinical variants of 
the disease, in terms of its site and number of intra-oral 
lesions in hepatitis C virus-infected and non-infected pa-
tients, suggests that this virus has a significant role in the 
progression of lichen planus.
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Psychological factors have recently been strongly 
associated with lichen planus, in particular high stress and 
anxiety levels. Although this association has been known 
for decades, difficulties in objectively measuring these 
variables has meant that only recently has the importance 
of anxiety and stress been widely recognized; these factors 
are now the target of numerous studies.
Soto-Araya et al.11 (2004) investigated the relation 
between psychological disorders -stress, anxiety and 
depression - and disease of the oral mucosa. The author 
applied psychological profile tests in 18 patients with re-
current aphthous stomatitis, nine with oral lichen planus, 
seven with burning mouth syndrome, and 20 with no appa-
rent lesion. The results suggested a statistically significant 
relation between the presence of psychological changes 
and the diseases that were studied. The authors found 
that stress levels were highest in patients with recurrent 
aphthous stomatitis and oral lichen planus. Anxiety levels 
were highest in all three groups of patients compared with 
the control group. Evidence of depression was observed 
especially in patients with the burning mouth syndrome. 
These results led to the conclusion that there was a close 
relation between psychological alterations and certain dise-
ase that affect the mouth; it also highlighted the influence 
of psychic factors on oral health.
Koray et al.12 (2003) studied the relation between 
anxiety and levels of cortisol - the stress hormone - in the 
saliva of 40 patients with oral lichen planus. The analysis 
compared anxiety and salivary cortisol levels in these 
patients with the control group; the authors concluded 
that both levels were considerably higher in patients with 
oral lichen planus compared to those without this disease, 
further strengthening the ties between altered stress and 
anxiety levels and oral lichen planus. Ivanovski et al.13 
(2005) has confirmed this conclusion after finding the 
same results in a basically similar study.
There are, therefore, major debates around the 
mechanisms by which lichen planus develops and why 
they occur. Although there is evidence that viral infections 
- especially those caused by the hepatitis C virus - and 
psychological disorder somatization, such as stress and 
anxiety, may be possible causes of this disease, informa-
tion is lacking to definitively confirm these connections. 
Further debates have arisen about the possible malignant 
nature of oral lichen planus.
CLINICAL FEATURES
Lichen planus is a frequent mucocutaneous disease 
that affects mostly women between the fifth and sixth 
decades of life.2,4,14-16 According to Laeijendecker et al.17 
(2005), however, the disease may also affect individuals 
aged below 18 years; the clinical features are the same 
as those that present in older adults, but the prognosis is 
more benign.
Clinically, oral lichen planus has specific and clearly 
identifiable features,18 usually presenting in one of two 
main forms - the reticular and the erosive forms - although 
other forms are not rare.14 In fact, according to Mollaoglu19 
(2000), four other forms were originally described: the 
papular, “plate-like”, bullous and atrophic forms.
The reticular form occurs more frequently and is 
characterized by white lacy streaks known as Wickham’s 
striae, which generally are surrounded by discrete erythe-
matous borders. Such feature may not be evident in certain 
sites, such as the dorsum of the tongue, where lesions 
present as keratotic plaques. The reticular form usually 
causes no symptoms; it involves the posterior jugal mucosa 
bilaterally. Other sites may be simultaneously involved, 
such as the upper and lateral surfaces of the tongue, the 
gums and the palate.14-15,19 
The erosive form is not as common as the reticular 
form, but it is more significant for patients, as the lesions 
are commonly symptomatic. Symptoms may range from 
discomfort to intensely painful episodes that interfere with 
chewing. Clinically, erosive lichen planus manifests as 
atrophic and erythematous areas frequently surrounded by 
radiating thin striae. In certain cases, the epithelium may 
separate if erosion is severe, resulting in a relatively rare 
form of the disease known as bullous lichen planus.14-15 
At times atrophy and ulceration is confined to the 
gingival mucosa, in a reaction pattern named desquamative 
gingivitis. Such cases should be biopsied for immunoflu-
orescence and optic microscopy of perilesional tissue, as 
benign mucous membrane pemphigoid and pemphigus 
vulgaris may present similarly.15 
Mignogna et al.20 (2005) assessed 700 patients with 
oral lichen planus and reported that 48% presented gingival 
involvement, and that lesions occurred only in the gums 
in 7.4% of the sample patients. The authors also found 
that 20% of cases of malignant transformation involved 
the gingival mucosa, further reinforcing the importance of 
histopathology in the final diagnosis of this disease.
Patients with oral lichen planus frequently present 
one or more extraoral lesions. Eisen4 (2002), for instance, 
mentions that about 25% of women with this disease also 
present concomitant vulvovaginal mucosal involvement, 
and that about 15% of all patients with this disease also 
have skin lesions. According to Neville et al.15 (2004), 
skin lesions have been classified as polygonal, pruritic, 
purple papules. These usually affect the flexor surfaces 
of extremities. Scoriation may not be visible, although 
lesions may be irritative; they are painful when scratched. 
Careful examination of the surface of papules reveals fine 
reticular white lacy streaks (Wickham’s striae). Other ex-
traoral sites are the nails, the scalp, the penile glans and 
the esophageal mucosa.
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Skin lesions facilitate considerably the diagnosis 
of lichen planus. However, with the exception of the 
reticular form, which has pathognomonic features, most 
cases are diagnosed histopathologically. A differential 
diagnosis should be made between erosive lichen planus 
and epidermoid carcinoma, discoid lupus erythematosus, 
chronic candidiasis, benign mucous membrane pemphi-
goid, morsicatio buccarum, lichenoid reaction to amalgam 
or to drugs, graft versus host disease, and erythema mul-
tiforme. Lichen planus reticularis should, in some cases, 
be differentiated from leukoplasia.14 
DIAGNOSIS AND TREATMENT
The typical clinical features of oral lichen planus are 
usually sufficient for the diagnosis of this condition. Still, a 
biopsy for histopathology is recommended to confirm the 
clinical diagnosis and mainly to exclude epithelial atypia 
and signs of malignancy.18 
The classical histopathological findings in oral lichen 
planus are: lichenification of the basement layer, followed 
by a marked layered lymphocytic infiltrate immediately 
Figure 1. Lichen planus. Histology section showing epithelial hyper-
parakeratosis, mild acanthosis and basement layer lichenification; 
also present is a layered marked lymphocyte infiltrate immediately 
underlying the epithelium. H/E - 400x.
underlying the epithelium; the presence of numerous eo-
sinophilic colloid bodies along the epithelial-connective 
tissue interface (Civatte bodies); absent, hyperplasic or, 
more frequently, sawtooth-shaped interpapillary ridges; va-
riable thickness of the spinous layer; and variable degrees 
of ortho or parakeratosis.14-15,21-22 (Figures 1 to 4)
Other conditions may, however, present similar 
histopathological findings to those of oral lichen planus; 
these include lichenoid reactions, lupus erythematosus, 
Figure 2. Lichen planus. Note areas of epithelial atrophy, and a layered 
marked lymphocyte infiltrate in the lamina propria immediately under-
lying the epithelium. H/E - 400x.
Figure 3. Lichen planus. The epithelium shows large keratinocytes 
containing prominent nuclei and basement layer liquefaction. De-
creased melanin pigmentation in the lamina propria, and a layered 
marked lymphocyte infiltrate immediately underlying the epithelium. 
H/E - 400x.
leukoplasia, erythroleukoplasia, and proliferative verru-
cous leukoplakia (PVL). In its initial phase, PVL presents 
clinical and histopathological findings that may easily be 
mistaken for those found in lichen planus. PVL, however, 
frequently reveals varied degrees of epithelial atrophy and 
high malignant transformation rates.23 
For this reason, Kolde et al.24 (2003) have sug-
gested using routine direct immunofluorescence in the 
diagnosis of oral lichen planus, particularly when other 
autoimmune diseases are included in the differential 
diagnosis. According to Regezi & Sciubba22 (2000), direct 
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immunofluorescence reveals the presence of fibrinogen 
along the basement membrane zone in 90% to 100% of 
cases. Although immunoglobulins and complement fac-
tors may also be found, they are much less common that 
fibrinogen deposits.
The histopathological diagnosis of oral lichen planus 
requires careful attention. Van der Meij & Van der Waal25 
(2003), for instance, found that in 42% of cases in which 
there was full agreement on the clinical diagnosis of this 
disease, there was no consensus in the histopathological 
diagnosis. Furthermore, in 50% of cases in which a histo-
pathological consensus was achieved, clinical agreement 
was lacking.
Some authors have suggested that erosive and 
reticular lichen planus should be considered in separate. 
According to Karatsaidis et al.26 (2003), the considerably 
increased cell proliferation in erosive lichen planus, com-
pared to the reticular form, indicates that the erosive form 
is more active; this underlies the importance of studying 
each form separately. Seoane et al.27 (2004) have reinforced 
this conclusion stating that the reticular and erosive forms 
have different biological behaviors.
Finally, Lukac et al.28 (2006) assessed serum concen-
trations of antibodies against desmoglein-1 and -3 by using 
the ELISA test in 32 patients with erosive lichen planus, 
in 25 patients with the reticular form, in 13 patients with 
recurrent aphthous stomatitis, and in 50 patients with no 
clinical signs. These authors found that differences in the 
serum concentration of antibodies against desmoglen-1 
and -3, indicating that the etiopathogenic mechanisms of 
erosive and reticular lichen planus are dissimilar.
The integrity of margins is a further issue in the 
histopathological diagnosis of oral lichen planus due to 
its malignant potential. Redahan et al.29 (2005) have sated 
that about 50% of biopsies show compromised margins, 
suggesting that examination of the adjacent tissues should 
be part of any monitoring protocol for this disease.
Having confirmed the diagnosis, therapy aims to 
relieve symptoms, given that curing the disease is not 
always possible. According to Regezi & Sciubba22 (2000), 
corticosteroids are the drugs of choice in the treatment of 
lichen planus, due to their ability to modulate the inflam-
matory and immunological responses. Topical use and 
local injection of steroids have been used successfully for 
controlling lichen planus. Systemic steroids may be used 
for severe cases. Adding antifungal drugs improves clinical 
results, apparently by eliminating Candida albicans, which 
grows secondarily in tissues affected by lichen planus. 
Antifungal drugs also prevent corticosteroid-associated 
fungal growth.
Other drugs have been used in the treatment of 
lichen planus with excellent results; these include immu-
nosuppressant such as cyclosporin30 and tacrolimus.31-32 
Theoretically, these drugs may increase the likelihood 
of malignant transformation, as they not only affect the 
immune systems, but act directly on cells.23 
Becker et al.33 (2006), for instance, believe that the 
relation between topical use of tacrolimus and the deve-
lopment of epidermoid carcinoma in patients with oral 
lichen planus is not limited only to immune suppression. 
These authors have suggested that tacrolimus appears to 
interfere on certain important intracellular signaling pa-
thways, especially those related with the p53 protein; this 
protein is also altered in a various types of cancer.
MALIGNANT POTENTIAL
In the past decades many papers have suggested 
that patients with oral lichen planus are at an increased 
risk of developing cancer, which led the World Health 
Organization to classify this disease as a premalignant 
condition. The association between oral lichen planus and 
epidermoid carcinoma, however, is still polemic; many 
authors believe that there are not enough data to prove 
this association. For these authors, most of the cases of 
malignant transformation could not be considered as such, 
as there were already alterations that suggested malignancy 
upon the initial diagnosis of lichen planus. Nevertheless, 
many papers highlight the malignant potential of this 
disease.21,34 
Eisen4 (2002) studied the malignant transformation 
potential of oral lichen planus, as well as its clinical fea-
tures and possible relation with systemic alterations. This 
author monitored 723 patients with oral lichen planus for 
a period between six months and eight years. The study 
found that epidermoid carcinoma developed in sites with 
Figure 4. Lichen planus. The epithelium shows basement layer lique-
faction. Civatte body (center). H/E - 400x.
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a previous diagnosis of lichen planus in 0.8% of patients. 
The author then suggested that periodic monitoring of 
these patients was essential, given the increased risk of 
developing epidermoid carcinoma in sites involved by 
oral lichen planus.
Gandolfo et al.35 (2004) undertook a similar study 
that evaluated 402 patients with oral lichen planus that 
had been diagnosed between January 1988 and July 1999; 
these patients were monitored periodically until February 
2001. During the follow-up period, two male (1.3%) and 
seven female (2.8%) patients developed epidermoid car-
cinoma; the risk of malignant transformation was higher 
among women compared to men. Additionally, patients 
infected by the hepatitis C virus had a threefold increase 
in the chance of developing oral cancer compared to 
non-infected patients. These results not only reinforce 
suspicions about the malignant transformation potential 
of lichen planus, but also have focused attention of the 
role of the hepatitis C virus in this process.
Xue et al.16 (2005) investigated the clinical features 
of oral lichen planus in 674 patients of the Stomatology 
Unit, Wuhan university, China, between 1963 and 2003. 
About 0.65% of the 674 patients developed epidermoid 
carcinoma in sites with a previous diagnosis of erosive or 
atrophic lichen planus, suggesting that both forms of the 
disease increase the risk of malignant transformation more 
than the reticular form. The authors also called attention 
to the need to monitor patients with lichen planus for 
many years, as there was one case in which malignant 
transformation occurred 21 years after the initial diagnosis 
of lichen planus.
The results above confirm those of Lanfranchi-
Tizeira et al.36 (2003). These authors evaluated 719 oral 
lichen planus cases diagnosed at the Oral Clinical and Pa-
thology Unit II, Dentistry School, Buenos Aires University, 
Argentina, between 1991 and 1997, and found that all the 
32 cases of malignant transformation (6,51%) occurred in 
atypical forms of lichen planus, such as presentation in 
the plaque, the erosive and the atrophic form.
Why such transformation occurs remains unclear. 
Mignogna et al.37 (2004) has suggested that currently there 
is sufficient evidence demonstrating that chronic inflam-
mation, which is the case of oral lichen planus, generates 
a cytokine-based microenvironment that affects cell sur-
vival, growth, proliferation and differentiation; this may 
consequently contribute to cancer initiation, promotion 
and progression.
Other authors, however, believe that transformation 
is favored by an altered expression of apoptosis-regulating 
proteins, such as the p53 protein. According to Neppelberg 
et al.38 (2001), the number of epithelial cells undergoing 
apoptosis is considerably increased in sites affected by 
lichen planus, compared to the normal epithelium.
Valente et al.39 (2001) analyzed p53 protein ove-
rexpression in the biopsies of 28 patients with oral lichen 
planus done periodically during 96 months. No dysplasia 
was seen in 15 of these patients across the study period 
(group 1). In seven patients there was synchronism be-
tween the diagnosis of lichen planus and the development 
of epidermoid carcinoma (group 2); in the remaining 
patients, this progression was seen months or years later 
(group 3). The percentage of p53-positive epithelial cells 
was considerably higher in groups 2 and 3 compared to 
group 1. The cell proliferation rate, evaluated by the im-
munohistochemical expression of the MIB-1 protein, was 
not statistically different among the groups. Although no 
conclusion is yet possible about the molecular pathways 
that cause oral lichen planus to undergo malignant trans-
formation, results suggest that an immunohistochemical 
assessment of p53 expression may become a useful tool 
for selecting those cases at a higher risk for malignancy.
Lee et al.40 (2005) investigated the expression of 
the p53 protein and the proliferating cell nuclear antigen 
(PCNA) in oral lichen planus and its relation with the 
clinical behavior of the disease and the habits of patients. 
The authors used immunohistochemical tests to evaluate 
the expression of those proteins in 56 patients, which were 
then compared with samples of normal, hyperkeratotic and 
dysplasic oral mucosa, and with epidermoid carcinoma 
samples. PCNA and p53 expression in oral lichen planus 
was similar to that found in hyperkeratotic mucosa, but 
higher than that seen in normal mucosa, and lower than 
that found in dysplasic mucosa and in the epidermoid 
carcinoma. There was, however, no significant correlation 
between the expression of both proteins and any clinical 
feature of the disease. But the expression of p53 was 
higher in patients with the habit of chewing a mixture 
of betel nuts with tobacco and slacked lime, while the 
expression of PCNA was higher in the atrophic forms of 
the disease compared to the hypertrophic forms. Patients 
with the atrophic forms of lichen planus and the habit 
described above had considerably higher expression of 
these proteins, similar to that found in dysplasic mucosa 
and in the epidermoid carcinoma. According to the au-
thors, these results confirm the premalignant nature of oral 
lichen planus; they suggest that the atrophic forms of this 
disease have a higher malignant potential, especially when 
associated with the abovementioned habit.
Bascones et al.41 (2005) investigated the influence 
of apoptosis and cell cycle interruption mechanisms in the 
malignant transformation process of oral lichen planus. 
They assessed the apoptotic rate by the terminal deoxyribo-
nucleotidyl transferase mediated dUTP nick end labelling 
(TUNEL) method and evaluated the immunohistochemical 
expression of bax, caspase-3 and p21 proteins in oral mu-
cosa samples of 32 patients with oral lichen planus. The 
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authors concluded that a low epithelial cell response to 
apoptosis and cell cycle interruption mechanisms could 
cause malignant transformation.
Although many studies have demonstrated the pre-
malignant nature of oral lichen planus, many other have 
stated the opposite. Sousa et al.42 (2005), for instance, 
found no connection between oral lichen planus and the 
epidermoid carcinoma when using criteria such as sex, 
race, age and site of increased disease prevalence; this 
suggests that the profile of lichen planus patients differs 
considerably from that observed in patients with the epi-
dermoid carcinoma.
Various authors believe that most of the cases 
of malignant transformation described in the literature 
should not be considered as such, as they show a range 
of epithelial atypia on the initial diagnosis, which would 
define a condition with distinct histopathological featu-
res named lichenoid dysplasia. According to Lodi et al.23 
(2005), inflammation present in oral lichen planus may 
cause cell alterations similar to those seen in epithelial 
atypia, making it even more difficult to differentiate from 
lichenoid dysplasia.
Recent papers have recast the idea that lichen 
planus and lichenoid dysplasia should be considered as 
two different entities. The presence of epithelial atypia is 
currently believed to be the factor that classifies a lesion 
as having malignant potential; thus, lichenoid dysplasia, 
rather than lichen planus, should be classified as prema-
lignant. The possibility of malignant transformation is a 
reflection of many intrinsic molecular alterations within 
cells, all of which are found in lichenoid dysplasia.43 
Kim et al.44 (2001) assessed the malignant potential 
of oral lichen planus by comparing the degree of gene-
tic instability in clinically cured cases and in those that 
had undergone malignant transformation. These authors 
concluded that lichenoid dysplasia should be seen as a 
high-risk premalignant lesion, and that chromosome nine 
monossomia may have an important role in the malignant 
transformation of this lesion.
Van der Meij et al.45 (2003) conducted a prospec-
tive study of 62 patients with oral lichen planus and 111 
patients with lichenoid dysplasia during 6.6 to 72 months. 
Three of 173 patients (1.7%), progressed to epidermoid 
carcinoma; malignant transformation in all cases develo-
ped from lichenoid dysplasia. The authors suggested that 
further prospective studies with larger series were needed 
before reaching a final conclusion about the malignant 
potential of oral lichen planus and lichenoid dysplasia. 
They also underlined that, whether lichen planus is or 
not considered as a premalignant lesion, the mere suspi-
cion of such a possibility justified long-term monitoring 
of these patients.
Mattsson et al.46 (2002) have stated that although 
there may be enough indications that lichen planus has 
malignant potential, its low rate makes periodic specialist 
monitoring of these patients financially unfeasible. Still, it 
is important that health professionals know the early signs 
of mouth cancer so that it may be detected in routine care. 
Additionally, patients should be instructed to inform any 
change in their condition.
CONCLUSION
Regardless of the polemic around oral lichen pla-
nus, which should be restricted to academic levels, in 
practice the mere possibility of malignant transformation 
justifies long-term monitoring of patients with this disease. 
This becomes even more evident given the difficulties in 
making the clinical and histopathological diagnosis of this 
condition. Care should be taken when informing patients 
about these issues to avoid excessive worry that would 
only worsen the clinical picture.
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